Cargando…
Bupropion Treatment for Stimulant Withdrawal in a Patient With Substance Use Disorder and Unspecified Bipolar Disorder
Patients presenting with comorbid stimulant use disorder is a common occurrence in nearly all medical specialties. New clinical strategies to care for patients experiencing stimulant withdrawal should be considered as an effort to improve clinical outcomes. Our patient, a woman in her early 20s with...
Autores principales: | Khan, Daanish Y, Behaeddin, Bita C, Uhlyar, Stepan, Parker, Jonathan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191240/ https://www.ncbi.nlm.nih.gov/pubmed/37206494 http://dx.doi.org/10.7759/cureus.37700 |
Ejemplares similares
-
Psychotic Cannabis Withdrawal: A Clinical Case
por: Ramos, Berta, et al.
Publicado: (2022) -
Management of unspecified anxiety disorder: Expert consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2023) -
Comparison of the efficacy of venlafaxine and bupropion in the treatment of depressive episode in patients with bipolar II disorder
por: Fakhri, Ahmad, et al.
Publicado: (2023) -
Catatonia Presentation as a Rare Alcohol Withdrawal Symptom in a Patient With No Past Psychiatry History: A Case Report
por: Nkemjika, Stanley, et al.
Publicado: (2021) -
Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder
por: Terry, Peyton H, et al.
Publicado: (2021)